La cadena de opciones muestra datos clave de las opciones de acciones de PainReform a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para PainReform..

PainReform (NASDAQ:PRFX) Bolsa, Cadena de Opciones

PainReform

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

AADI

APTO

CADL

CARA

HUMA

MESO

MOBX

MTEM

NVNI

OCEA

PRFX

QUBT

ZCAR

FedEx sube un 8,7% con resultados sólidos y una nueva estrategia. Descubre otras acciones destacadas en premercado hoy.

Las acciones de FedEx (FDX) suben alrededor de un 9%; 20 acciones que se mueven en premercado

PainReform Ltd

Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) will release earnings results for the first quarter, after the closing <a href="https://www.benzinga.com/quote/snap/earnings">bell on Tuesday, April 29</a>.
Analysts expect the Santa Monica, California-based company to report quarterly earnings at 4 cents per share, up from 3 cents per share in the year-ago period. Snap projects to report quarterly revenue at $1.35 billion, compared to $1.19 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Feb. 4, Snap reported quarterly earnings of 16 cents per share, which beat the analyst consensus estimate of 14 cents. Quarterly revenue came in at $1.55 billion, which beat the analyst consensus estimate of $1.54 billion and is an increase over revenue of $1.36 billion from the same period last year.
Snap shares rose 3.4% to close at $8.83 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/WBA/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Stifel analyst Mark Kelley maintained a Hold rating and cut the price target from $11 to $8 on April 23, 2025. This analyst has an accuracy rate of 83%.</li>
<li>Morgan Stanley analyst Brian Nowak maintained an Equal-Weight rating and slashed the price target from $10 to $8 on April 17, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Canaccord Genuity analyst Maria Ripps maintained a Hold rating and slashed the price target from $13 to $10 on April 17, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Citigroup analyst Ronald Josey maintained a Neutral rating and cut the price target from $13.5 to $9 on April 14, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Goldman Sachs analyst Eric Sheridan maintained a Neutral rating and cut the price target from $13.5 to $9.5 on April 14, 2025. This analyst has an accuracy rate of 78%.</li>
</ul>
Considering buying SNAP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29033106/image-204-1024x584.png" alt="" class="wp-image-892210" style="width:551px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29033106/image-204-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29033106/image-204-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29033106/image-204-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29033106/image-204.png 1101w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45038052/top-2-industrials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Industrials Stocks That May Fall Off A Cliff This Quarter</a></li>
</ul>
Photo via Shutterstock

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

SNAP

Snap Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Rosenblatt analyst Mike Genovese upgraded the rating for Arista Networks Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) from Sell to Neutral and raised the price target from $55 to $85. Arista Networks shares closed at $78.31 on Monday. <a href="https://www.benzinga.com/quote/anet/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Damian Karas upgraded the rating for Crane Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) from Neutral to Buy and increased the price target from $157 to $190. Crane shares closed at $148.67 on Monday. <a href="https://www.benzinga.com/quote/CR/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying ANET stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29081343/image-214-1024x584.png" alt="" class="wp-image-892707" style="width:552px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29081343/image-214-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29081343/image-214-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29081343/image-214-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29081343/image-214.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45060164/general-motors-coca-cola-and-3-stocks-to-watch-heading-into-tuesday">General Motors, Coca-Cola And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Upgrades

Pre-Market Outlook

ANET

VLRS

This Arista Networks Analyst Is No Longer Bearish; Here Are Top 2 Upgrades For Tuesday

Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) is in the spotlight ahead earnings Tuesday. Here&#8217;s what you <a href="https://www.benzinga.com//node/45046664">need to know.</a>
What To Know: Analysts&#8217; estimate first-quarter earnings of 3 cents per share and revenue of $1.35 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
The company previously guided for revenue between $1.23 billion and $1.36 billion and adjusted EBITDA between $40 million and $75 million for the first-quarter.
Snap also expects infrastructure costs per daily active user to be between 82 cents and 87 cents. Content, developer, advertising partner and other costs are expected to represent 19% to 20% of revenue.
In its last letter to shareholders, the company said, &#8220;As we look ahead to 2025, we see additional opportunities to invest productively in scaling our business given the foundational improvements we have made to our ad platform and the momentum we have established in our go to market initiatives, particularly the SMB segment. Our investment plans for 2025 reflect this optimism, alongside a strong commitment to make further financial progress towards profitability as we scale.&#8221;
See Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/04/45067585/amazon-stock-tumbles-as-white-house-calls-tariff-visibility-plans-a-hostile-act">Amazon Stock Tumbles As White House Calls Tariff Visibility Plans A &#8216;Hostile&#8217; Act</a>
SNAP Price Action: At the time of writing, Snap stock is trading 1.0.8% higher at $8.92, per data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
Image: via Shutterstock

Movers

What's Going On With Snap Stock Tuesday?

UBS analyst Timothy Arcuri maintains Skyworks Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) with a Neutral and lowers the price target from $70 to $65.

SWKS

UBS Maintains Neutral on Skyworks Solutions, Lowers Price Target to $65

UBS analyst John Nadel maintains Principal Financial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) with a Neutral and lowers the price target from $93 to $80.

UBS Maintains Neutral on Principal Financial Group, Lowers Price Target to $80

UBS analyst Pradeep Ramani maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Neutral and lowers the price target from $55 to $40.

UBS Maintains Neutral on ON Semiconductor, Lowers Price Target to $40

WIIM

Wells Fargo shares are trading higher after the company's board authorized a $40 billion stock repurchase program.

UBS analyst Kunal Madhukar maintains Match Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) with a Neutral and lowers the price target from $34 to $31.

MTCH

UBS Maintains Neutral on Match Group, Lowers Price Target to $31

Correction: Guggenheim analyst Michael Schmidt downgrades SpringWorks Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) from Buy to Neutral and lowers the price target from $77 to $47. (Analyst Firm change from Stephens &amp; Co. to Guggenheim)

Downgrades

SWTX

Correction: Guggenheim Downgrades SpringWorks Therapeutics to Neutral, Lowers Price Target to $47 (Firm change from Stephens & Co. to Guggenheim)

BMO Capital analyst Michael Zaremski maintains Selective Insurance Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGI#NASDAQ">SIGI</a>) with a Outperform and raises the price target from $92 to $96.

SIGI

BMO Capital Maintains Outperform on Selective Insurance Gr, Raises Price Target to $96

UBS analyst Taylor McGinnis maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Neutral and lowers the price target from $350 to $310.

MNDY

UBS Maintains Neutral on Monday.Com, Lowers Price Target to $310

BMO Capital analyst Ari Klein maintains SBA Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) with a Market Perform and raises the price target from $230 to $240.

SBAC

BMO Capital Maintains Market Perform on SBA Communications, Raises Price Target to $240

UBS analyst Pradeep Ramani maintains Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) with a Buy and lowers the price target from $70 to $55.

MCHP

UBS Maintains Buy on Microchip Technology, Lowers Price Target to $55

AZZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) has outperformed the market over the past 20 years by 8.88% on an annualized basis producing an average annual return of 16.92%. Currently, AZZ has a market capitalization of $2.57 billion. 
Buying $1000 In AZZ: If an investor had bought $1000 of AZZ stock 20 years ago, it would be worth $22,594.59 today based on a price of $86.00 for AZZ at the time of writing.
<h3>AZZ's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745937911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

BMO Capital analyst Andrew Strelzik maintains Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) with a Outperform and raises the price target from $515 to $540.

BMO Capital Maintains Outperform on Domino's Pizza, Raises Price Target to $540

UBS analyst Danielle Antalffy maintains InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) with a Neutral and lowers the price target from $19 to $16.25.

INMD

UBS Maintains Neutral on InMode, Lowers Price Target to $16.25

BMO Capital analyst James Thalacker maintains CMS Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMS#NYSE">CMS</a>) with a Outperform and raises the price target from $77 to $79.

BMO Capital Maintains Outperform on CMS Energy, Raises Price Target to $79

UBS analyst Timothy Arcuri maintains GLOBALFOUNDRIES (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) with a Neutral and lowers the price target from $45 to $37.

UBS Maintains Neutral on GLOBALFOUNDRIES, Lowers Price Target to $37

Piper Sandler analyst James Fish maintains F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) with a Neutral and raises the price target from $262 to $269.

FFIV

Piper Sandler Maintains Neutral on F5, Raises Price Target to $269

UBS analyst Timothy Arcuri maintains Entegris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NASDAQ">ENTG</a>) with a Neutral and lowers the price target from $115 to $90.

Comments

PainReform

PainReform (PRFX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL